Product Description
AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. (Sourced from: https://www.fda.gov/vaccines-blood-biologics/vaccines/afluria-quadrivalent-afluria-quadrivalent-southern-hemisphere)
Mechanisms of Action: Vaccine
Novel Mechanism: No
Modality: Vaccine
Route of Administration: Intramuscular
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Argentina | Australia | Austria | Belgium | Chile | Colombia | Croatia | Germany | Italy | Korea | New Zealand | Portugal | Spain
Approved Indications: None
Known Adverse Events: None
Company: Seqirus
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: Australia
Active Clinical Trial Count: 1
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Lupus Erythematosus, Systemic
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
ACTRN12623000397617 |
TWIRL | P2 |
Not yet recruiting |
Lupus Erythematosus, Systemic |
2024-08-31 |
2024-08-29 |
Patient Enrollment|Start Date|Treatments|Trial Status |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
01/01/2006 |
PubMed |
Influenza Vaccines. |
|
09/08/2025 |
News Article |
Corner Therapeutics Research Opens Path to Universal, Long-Lasting Flu Vaccine and Signals Promise for Oncology |
|
07/09/2024 |
News Article |
CSL Seqirus Begins Shipping Its Portfolio of Influenza Vaccines for the 2024/25 Flu Season |
|
10/16/2023 |
PubMed |
Influenza vaccine for 2023-2024. |
|
09/13/2023 |
News Article |
FFF Enterprises Inc. Adds COVID-19 Vaccines and Respiratory Syncytial Virus (RSV) Products to Its Comprehensive, Expanding Portfolio |
|
07/17/2023 |
News Article |
CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2023/24 U.S. Season |
|
09/21/2022 |
PubMed |
A Prospective Cohort Study on Pregnancy Outcomes of Persons Immunized with a Seasonal Quadrivalent Inactivated Influenza Vaccine during Pregnancy. |